Category Archives: Non-U.S. Practice

UK Patent Applications On The Fast Track – Nothing Extra Payable

Posted on February 8, 2011 by Warren Woessner

Guest post from Paul Cole of Lucas & Co. Claims searched, examined and approved for grant (subject to publication and possible third party comments) within six working days? Not only theoretically possible but actually achieved in an application filed earlier … Continue reading →

EMA Draft Guidelines For Biosimilar Antibodies Released

Posted on December 29, 2010 by Warren Woessner

From Dr. Stefan Danner On November 18, 2010, the European Medicines Agency (EMA) released draft versions of two guidelines relating to the regulatory approval of monoclonal antibodies: the “Guideline on biological medicinal products containing monoclonal antibodies”1 and the “Guideline on … Continue reading →

Posted in Non-U.S. Practice | Tagged biotechnology law, Dr. Stefan Danner, EMA, intellectual property, Warren Woessner | Leave a comment

Newsflash! EPO announces that it does not require search results from priority applications filed at the USPTO, JPO and UKIPO

Posted on December 13, 2010 by Warren Woessner

From Marks & Clerk — This is a correction to the post of December 10th. Late yesterday – December 9, 2010 – a decision of the President of the European Patent Office (EPO) was posted on the EPO website confirming that … Continue reading →

Posted in Non-U.S. Practice | Tagged EPO, intellectual property, ip, IP law tools, marks & clerk, Warren Woessner | Leave a comment

Let’s Get Physical! Australian Patent Office Wrestles With Method Claims

Posted on November 17, 2010 by Warren Woessner

The Australian Patent Office appears to grappling with the requirement that a physical effect take place in order for a business method to be patentable. This note sent by Bill Bennett of Pizzeys Patent and Trademark Attorneys raises interesting issues about the need for … Continue reading →